Prevalence and Outcomes of COVID −19 Patients with Happy Hypoxia: A Systematic Review

References

• Livingston E, Bucher K. Coronavirus disease 2019 (COVID-19) in Italy. JAMA. 2020;323(14):1335. doi:10.1001/jama.2020.4344
   PubMedGoogle Scholar
• Gable L, Courtney B, Gatter R, et al. Global public health legal responses to H1N1. J Law Med Ethics. 2011;39(Suppl1):46–50. doi:10.1111/j.1748-720X.2011.00565.x
   Web of Science ®Google Scholar
• Ucinotta D, Vanelli M. WHO declares COVID‐19 a pandemic. Acta Bio Med Atenei Parmensis. 2020;91(1):157‐160.
   Google Scholar
• World Health Organization. Coronavirus (COVID-19) Dashboard. Available from: https://covid19.who.int/. Accessed August 30, 2022.
   Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. PMID: 32109013; PMCID: PMC7092819. doi:10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Johnson KD, Harris C, Cain JK, Hummer C, Goyal H, Perisetti A. Pulmonary and extra-pulmonary clinical manifestations of COVID-19. Front Med. 2020;7:526. PMID: 32903492; PMCID: PMC7438449. doi:10.3389/fmed.2020.00526
   Web of Science ®Google Scholar
• Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020;382(24):2372–2374. doi:10.1056/NEJMc2010419
   PubMed Web of Science ®Google Scholar
• Gallo Marin B, Aghagoli G, Lavine K, et al. Predictors of COVID-19 severity: a literature review. Rev Med Virol. 2021;31(1):1–10. doi:10.1002/rmv.2146
   PubMed Web of Science ®Google Scholar
• Levitan R. The infection That’s silently killing coronavirus patients; 2010. Available from: https://www.nytimes.com/2020/04/20/opinion/sunday/coronavirus-testing-pneumonia.html/. Accessed April 12, 2022.
   Google Scholar
• Akiyama Y, Morioka S, Asai Y, et al. Risk factors associated with asymptomatic hypoxemia among COVID-19 patients: a retrospective study using the nationwide Japanese registry, COVIREGI-JP. J Infect Public Health. 2022;15(3):312–314. doi:10.1016/j.jiph.2022.01.014
   Web of Science ®Google Scholar
• Brouqui P, Amrane S, Million M, et al. Asymptomatic hypoxia in COVID-19 is associated with poor outcome. Int J Infect Dis. 2021;102:233–238. doi:10.1016/j.ijid.2020.10.067
   PubMed Web of Science ®Google Scholar
• Busana M, Gasperetti A, Giosa L, et al. Prevalence and outcome of silent hypoxemia in COVID-19. Minerva Anestesiol. 2021;87(3):325–333. doi:10.23736/S0375-9393.21.15245-9
   PubMed Web of Science ®Google Scholar
• Alhusain F, Alromaih A, Alhajress G, et al. Predictors and clinical outcomes of silent hypoxia in COVID-19 patients, a single-center retrospective cohort study. J Infect Public Health. 2021;14(11):1595–1599. doi:10.1016/j.jiph.2021.09.007
   Web of Science ®Google Scholar
• Sirohiya P, Elavarasi A, Sagiraju HKR, et al. Silent Hypoxia in Coronavirus disease-2019: is it more dangerous? -A retrospective cohort study. medRxiv preprint. 2021. doi:10.1101/2021.08.26.21262668
   Google Scholar
• García-Grimshaw M, Flores-Silva FD, Chiquete E, et al. Characteristics and predictors for silent hypoxemia in a cohort of hospitalized COVID-19 patients. Auton Neurosci. 2021;235:102855. doi:10.1016/j.autneu.2021.102855
   Web of Science ®Google Scholar
• Bepouka B, Situakibanza H, Odio O, et al. Happy Hypoxia in COVID-19 patients at Kinshasa University Hospital (the Democratic Republic of the Congo): frequency and vital outcome. J Biosci Med. 2021;9:12–20. doi:10.4236/jbm.2021.92002
   Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605. doi:10.1007/s10654-010-9491-z
   PubMed Web of Science ®Google Scholar
• Rahman AE, Hossain AT, Nair H, et al. Prevalence of hypoxemia in children with pneumonia in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Glob Health. 2022;10(3):e348–e359. doi:10.1016/S2214-109X(21)00586-6
   Web of Science ®Google Scholar
• Cardona S, Downing J, Alfalasi R, et al. Intubation rate of patients with hypoxia due to COVID-19 treated with awake proning: a meta-analysis. Am J Emerg Med. 2021;43:88–96. doi:10.1016/j.ajem.2021.01.058
   PubMed Web of Science ®Google Scholar
• Mohammadi M, Khafaee Pour Khamseh A, Varpaei HA. Invasive Airway “Intubation” in COVID-19 patients; statistics, causes, and recommendations: a review article. Anesth Pain Med. 2021;11(3):e115868. PMID: 34540642; PMCID: PMC8438719. doi:10.5812/aapm.115868
   Google Scholar
• O’Donnell CR, Friedman LS, Russomanno JH, Rose RM. Diminished perception of inspiratory-resistive loads in insulin-dependent diabetics. N Engl J Med. 1988;319(November(21)):1369–1373. doi:10.1056/NEJM198811243192102
   Web of Science ®Google Scholar
• Cretikos MA, Bellomo R, Hillman K, Chen J, Finfer S, Flabouris A. Respiratory rate: the neglected vital sign. Med J Aust. 2008;188(11):657–659. doi:10.5694/j.1326-5377.2008.tb01825.x
   PubMed Web of Science ®Google Scholar
• Klok FA, Kruip MJHA, van der Meer NJM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020;191:148–150. doi:10.1016/j.thromres.2020.04.041
   PubMed Web of Science ®Google Scholar
• Iba T, Gando S, Thachil J. Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan. J Thromb Haemost. 2014;12:1010–1019. doi:10.1111/jth.12596
   Web of Science ®Google Scholar
• Mousavi S, Moradi M, Khorshidahmad T, Motamedi M. Anti-inflammatory effects of heparin and its derivatives: a systematic review. Adv Pharmacol Sci. 2015;2015:507151. doi:10.1155/2015/507151
   PubMedGoogle Scholar
• Hoppensteadt D, Fareed J, Klein AL, Jasper SE, Apperson-Hansen C, Lieber EA. Comparison of anticoagulant and anti-inflammatory responses using enoxaparin versus unfractionated heparin for transesophageal echocardiography-guided cardioversion of atrial fibrillation. Am J Cardiol. 2008;102:842–846. doi:10.1016/j.amjcard.2008.05.025
   PubMed Web of Science ®Google Scholar
• Ranucci M, Ballotta A, Di Dedda U, Bayshnikova E, Dei Poli M, Resta M. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. 2020;18:1747–1751. doi:10.1111/jth.14854
   PubMed Web of Science ®Google Scholar
• Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18:1094–1099. doi:10.1111/jth.14817
   PubMed Web of Science ®Google Scholar
• Iba T, Nisio MD, Levy JH, Kitamura N, Thachil J. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open. 2017;7:e017046. doi:10.1136/bmjopen-2017-017046
   PubMed Web of Science ®Google Scholar
• Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18:1421–1424. doi:10.1111/jth.14830
   PubMed Web of Science ®Google Scholar
• Hadid T, Kafri Z, Al-Katib A. Coagulation and anticoagulation in COVID-19. Blood Rev. 2021;47:100761. PMID: 33067035; PMCID: PMC7543932. doi:10.1016/j.blre.2020.100761
   PubMed Web of Science ®Google Scholar
• Gupta RK, Marks M, Samuels THA, et al. Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study. Eur Respir J. 2020;56:2003498. doi:10.1183/13993003.03498-2020
   PubMed Web of Science ®Google Scholar
• Mejía F, Medina C, Cornejo E, et al. Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru. PLoS One. 2020;15:e0244171. doi:10.1371/journal.pone.0244171
   Web of Science ®Google Scholar
• Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369. doi:10.1136/bmj.m1966
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult in-patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069. doi:10.1001/jama.2020.1585
   PubMed Web of Science ®Google Scholar
• Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46:1099–1102. doi:10.1007/s00134-020-06033-2
   PubMed Web of Science ®Google Scholar
• Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475–481. doi:10.1016/S2213-2600(20)30079-5
   PubMed Web of Science ®Google Scholar
• Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. Covid-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;201:1299–1300. doi:10.1164/rccm.202003-0817LE
   PubMed Web of Science ®Google Scholar
• Jiang B, Wei H. Oxygen therapy strategies and techniques to treat hypoxia in COVID-19 patients. Eur Rev Med Pharmacol Sci. 2020;24(19):10239–10246. PMID: 33090435; PMCID: PMC9377789. doi:10.26355/eurrev_202010_23248
   PubMed Web of Science ®Google Scholar
• Ramanathan K, Shekar K, Ling RR, et al. Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis. Crit Care. 2021;25(1):211. PMID: 34127027; PMCID: PMC8201440. doi:10.1186/s13054-021-03634-1
   Web of Science ®Google Scholar